Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.7500
0.00 (0.00%)
Jul 31, 2026, 4:10 PM AEST
Starpharma Holdings Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 13.86 | 4.91 | 8.29 | 4.21 | 4.9 | 2.15 |
Other Revenue | 0.72 | 0.94 | 1.47 | 0.14 | 0.26 | 1.34 |
| 14.58 | 5.85 | 9.76 | 4.34 | 5.16 | 3.49 | |
Revenue Growth | 149.20% | -40.04% | 124.64% | -15.87% | 48.04% | -50.99% |
Cost of Revenue | 10.27 | 9.58 | 10.69 | 12.36 | 14.46 | 15.87 |
Gross Profit | 4.31 | -3.73 | -0.93 | -8.02 | -9.29 | -12.38 |
Selling, General & Admin | 7.54 | 6.26 | 7.24 | 7.62 | 6.86 | 7.35 |
Operating Expenses | 7.54 | 6.26 | 7.24 | 7.62 | 6.86 | 7.35 |
Operating Income | -3.23 | -9.99 | -8.17 | -15.64 | -16.15 | -19.73 |
Pretax Income | -3.23 | -9.99 | -8.17 | -15.64 | -16.15 | -19.73 |
Earnings From Continuing Operations | -3.23 | -9.99 | -8.17 | -15.64 | -16.15 | -19.73 |
Net Income | -3.23 | -9.99 | -8.17 | -15.64 | -16.15 | -19.73 |
Net Income to Common | -3.23 | -9.99 | -8.17 | -15.64 | -16.15 | -19.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 419 | 417 | 411 | 409 | 407 | 397 |
Shares Outstanding (Diluted) | 419 | 417 | 411 | 409 | 407 | 397 |
Shares Change | 0.32% | 1.40% | 0.59% | 0.53% | 2.53% | 6.62% |
EPS (Basic) | -0.01 | -0.02 | -0.02 | -0.04 | -0.04 | -0.05 |
EPS (Diluted) | -0.01 | -0.02 | -0.02 | -0.04 | -0.04 | -0.05 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -1.1 | -6.8 | -7.07 | -14.93 | -14 | -15.05 |
Free Cash Flow Per Share | -0.00 | -0.02 | -0.02 | -0.04 | -0.03 | -0.04 |
Gross Margin | 29.59% | -63.74% | -9.52% | -184.57% | -180.05% | - |
Operating Margin | -22.16% | -170.77% | -83.69% | -360.07% | -312.94% | -565.87% |
Profit Margin | -22.16% | -170.77% | -83.69% | -360.07% | -312.94% | -565.87% |
Free Cash Flow Margin | -7.55% | -116.26% | -72.43% | -343.82% | -271.19% | -431.72% |
EBITDA | -2.96 | -9.72 | -7.85 | -15.25 | -15.8 | -19.43 |
EBITDA Margin | -20.32% | -166.21% | -80.45% | - | - | - |
D&A For EBITDA | 0.27 | 0.27 | 0.32 | 0.39 | 0.36 | 0.3 |
EBIT | -3.23 | -9.99 | -8.17 | -15.64 | -16.15 | -19.73 |
EBIT Margin | -22.16% | -170.77% | -83.69% | - | - | - |